2/26/2014 12:26:28 PM
NEWTON, MA--(Marketwired - Feb 26, 2014) - Empiriko, a clinical intelligence company, and Interchim, Inc., a leader in design and manufacturing of laboratory instruments, today announced a partnership agreement under which Empiriko will leverage Interchim's PuriFlash®/MassSpec (MS) technology to conduct near real-time and cost effective in vitro and ex-vivo drug metabolism studies using its Biomimiks™ technology.
Help employers find you! Check out all the jobs and post your resume.
comments powered by